^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

CD19/NKG2DL CAR-T Therapeutic

i
Other names: CD19/NKG2DL CAR-T Therapeutic, NKG2D-based dual CAR T
Associations
Trials
Company:
Celyad Oncology
Drug class:
CD19-targeted CAR-T immunotherapy, NKG2D-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials